Results 191 to 200 of about 271,187 (352)
Aims To evaluate the effects of vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) oestrogen receptor degrader, on the pharmacokinetics of dabigatran (a P‐glycoprotein [P‐gp] substrate) and rosuvastatin (a breast cancer resistance protein [BCRP] substrate).
Derek Z. Yang+9 more
wiley +1 more source
Hormonal and electrolyte predictors for methotrexate versus surgery in ectopic pregnancy. [PDF]
Başkıran Y+3 more
europepmc +1 more source
α‐mangostin (α‐MG) significantly affected tofacitinib metabolism by competing for the same site in CYP3A4. Co‐administration of these two medicines poses a potential herb–drug interaction. ABSTRACT This study investigated the effects of α‐mangostin (α‐MG) on the pharmacokinetics of tofacitinib in vitro and in vivo, aiming to recommend its appropriate ...
Jiange Yao+6 more
wiley +1 more source
A case report of cutaneous Langerhans cell Histiocytosis in an infant: a therapeutic challenge. [PDF]
Khanje L, Khanje K, Alqato S.
europepmc +1 more source
SYNTHESIS OF METHOTREXATE POLYGLUTAMATES IN CULTURED HUMAN CELLS [PDF]
David S. Rosenblatt+5 more
openalex +1 more source
Coadministration of the xanthine oxidase inhibitor, febuxostat, delayed elimination of methotrexate, at least in part, by noncompetitive inhibition of human organic anion transporter 3‐mediated methotrexate transport at clinical concentrations. The findings of this study provide novel information on drug interactions associated with febuxostat ...
Kenji Ikemura+3 more
wiley +1 more source
Two Consecutive Days of Low-Dose Methotrexate Toxicity: A Diagnostic Challenge. [PDF]
Harimohan H+5 more
europepmc +1 more source